Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Prostate Specific Antigen Market Research Report 2019-2025

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Prostate Specific Antigen Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Prostate Specific Antigen Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Prostate Specific Antigen Market Size Growth Rate by Type
    • 1.4.2 G-115
    • 1.4.3 INO-5150
    • 1.4.4 ADXS-PSA
    • 1.4.5 AEZS-120
    • 1.4.6 Others
  • 1.5 Market by Application
    • 1.5.1 Global Prostate Specific Antigen Market Size Growth Rate by Application
    • 1.5.2 Prostate Cancer
    • 1.5.3 Metastatic Hormone Refractory Prostate Cancer
    • 1.5.4 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Prostate Specific Antigen Market Size, Estimates and Forecasts
    • 2.1.1 Global Prostate Specific Antigen Revenue 2015-2026
    • 2.1.2 Global Prostate Specific Antigen Sales 2015-2026
  • 2.2 Global Prostate Specific Antigen, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Prostate Specific Antigen Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Prostate Specific Antigen Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Prostate Specific Antigen Competitor Landscape by Players

  • 3.1 Prostate Specific Antigen Sales by Manufacturers
    • 3.1.1 Prostate Specific Antigen Sales by Manufacturers (2015-2020)
    • 3.1.2 Prostate Specific Antigen Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Prostate Specific Antigen Revenue by Manufacturers
    • 3.2.1 Prostate Specific Antigen Revenue by Manufacturers (2015-2020)
    • 3.2.2 Prostate Specific Antigen Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Prostate Specific Antigen Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Prostate Specific Antigen Revenue in 2019
    • 3.2.5 Global Prostate Specific Antigen Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Prostate Specific Antigen Price by Manufacturers
  • 3.4 Prostate Specific Antigen Manufacturing Base Distribution, Product Types
    • 3.4.1 Prostate Specific Antigen Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Prostate Specific Antigen Product Type
    • 3.4.3 Date of International Manufacturers Enter into Prostate Specific Antigen Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Prostate Specific Antigen Market Size by Type (2015-2020)
    • 4.1.1 Global Prostate Specific Antigen Sales by Type (2015-2020)
    • 4.1.2 Global Prostate Specific Antigen Revenue by Type (2015-2020)
    • 4.1.3 Prostate Specific Antigen Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Prostate Specific Antigen Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Prostate Specific Antigen Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Prostate Specific Antigen Revenue Forecast by Type (2021-2026)
    • 4.2.3 Prostate Specific Antigen Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Prostate Specific Antigen Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Prostate Specific Antigen Market Size by Application (2015-2020)
    • 5.1.1 Global Prostate Specific Antigen Sales by Application (2015-2020)
    • 5.1.2 Global Prostate Specific Antigen Revenue by Application (2015-2020)
    • 5.1.3 Prostate Specific Antigen Price by Application (2015-2020)
  • 5.2 Prostate Specific Antigen Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Prostate Specific Antigen Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Prostate Specific Antigen Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Prostate Specific Antigen Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Prostate Specific Antigen by Country
    • 6.1.1 North America Prostate Specific Antigen Sales by Country
    • 6.1.2 North America Prostate Specific Antigen Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Prostate Specific Antigen Market Facts & Figures by Type
  • 6.3 North America Prostate Specific Antigen Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Prostate Specific Antigen by Country
    • 7.1.1 Europe Prostate Specific Antigen Sales by Country
    • 7.1.2 Europe Prostate Specific Antigen Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Prostate Specific Antigen Market Facts & Figures by Type
  • 7.3 Europe Prostate Specific Antigen Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Prostate Specific Antigen by Region
    • 8.1.1 Asia Pacific Prostate Specific Antigen Sales by Region
    • 8.1.2 Asia Pacific Prostate Specific Antigen Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Prostate Specific Antigen Market Facts & Figures by Type
  • 8.3 Asia Pacific Prostate Specific Antigen Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Prostate Specific Antigen by Country
    • 9.1.1 Latin America Prostate Specific Antigen Sales by Country
    • 9.1.2 Latin America Prostate Specific Antigen Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Prostate Specific Antigen Market Facts & Figures by Type
  • 9.3 Central & South America Prostate Specific Antigen Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Prostate Specific Antigen by Country
    • 10.1.1 Middle East and Africa Prostate Specific Antigen Sales by Country
    • 10.1.2 Middle East and Africa Prostate Specific Antigen Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Prostate Specific Antigen Market Facts & Figures by Type
  • 10.3 Middle East and Africa Prostate Specific Antigen Market Facts & Figures by Application

11 Company Profiles

  • 11.1 Advaxis, Inc.
    • 11.1.1 Advaxis, Inc. Corporation Information
    • 11.1.2 Advaxis, Inc. Description and Business Overview
    • 11.1.3 Advaxis, Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Advaxis, Inc. Prostate Specific Antigen Products Offered
    • 11.1.5 Advaxis, Inc. Related Developments
  • 11.2 Aeterna Zentaris Inc.
    • 11.2.1 Aeterna Zentaris Inc. Corporation Information
    • 11.2.2 Aeterna Zentaris Inc. Description and Business Overview
    • 11.2.3 Aeterna Zentaris Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Aeterna Zentaris Inc. Prostate Specific Antigen Products Offered
    • 11.2.5 Aeterna Zentaris Inc. Related Developments
  • 11.3 Bavarian Nordic A/S
    • 11.3.1 Bavarian Nordic A/S Corporation Information
    • 11.3.2 Bavarian Nordic A/S Description and Business Overview
    • 11.3.3 Bavarian Nordic A/S Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Bavarian Nordic A/S Prostate Specific Antigen Products Offered
    • 11.3.5 Bavarian Nordic A/S Related Developments
  • 11.4 Curevac AG
    • 11.4.1 Curevac AG Corporation Information
    • 11.4.2 Curevac AG Description and Business Overview
    • 11.4.3 Curevac AG Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Curevac AG Prostate Specific Antigen Products Offered
    • 11.4.5 Curevac AG Related Developments
  • 11.5 GenSpera, Inc.
    • 11.5.1 GenSpera, Inc. Corporation Information
    • 11.5.2 GenSpera, Inc. Description and Business Overview
    • 11.5.3 GenSpera, Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 GenSpera, Inc. Prostate Specific Antigen Products Offered
    • 11.5.5 GenSpera, Inc. Related Developments
  • 11.6 Inovio Pharmaceuticals, Inc.
    • 11.6.1 Inovio Pharmaceuticals, Inc. Corporation Information
    • 11.6.2 Inovio Pharmaceuticals, Inc. Description and Business Overview
    • 11.6.3 Inovio Pharmaceuticals, Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Products Offered
    • 11.6.5 Inovio Pharmaceuticals, Inc. Related Developments
  • 11.7 OncBioMune Pharmaceuticals Inc.
    • 11.7.1 OncBioMune Pharmaceuticals Inc. Corporation Information
    • 11.7.2 OncBioMune Pharmaceuticals Inc. Description and Business Overview
    • 11.7.3 OncBioMune Pharmaceuticals Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Products Offered
    • 11.7.5 OncBioMune Pharmaceuticals Inc. Related Developments
  • 11.1 Advaxis, Inc.
    • 11.1.1 Advaxis, Inc. Corporation Information
    • 11.1.2 Advaxis, Inc. Description and Business Overview
    • 11.1.3 Advaxis, Inc. Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 Advaxis, Inc. Prostate Specific Antigen Products Offered
    • 11.1.5 Advaxis, Inc. Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Prostate Specific Antigen Market Estimates and Projections by Region
    • 12.1.1 Global Prostate Specific Antigen Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Prostate Specific Antigen Revenue Forecast by Regions 2021-2026
  • 12.2 North America Prostate Specific Antigen Market Size Forecast (2021-2026)
    • 12.2.1 North America: Prostate Specific Antigen Sales Forecast (2021-2026)
    • 12.2.2 North America: Prostate Specific Antigen Revenue Forecast (2021-2026)
    • 12.2.3 North America: Prostate Specific Antigen Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Prostate Specific Antigen Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Prostate Specific Antigen Sales Forecast (2021-2026)
    • 12.3.2 Europe: Prostate Specific Antigen Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Prostate Specific Antigen Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Prostate Specific Antigen Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Prostate Specific Antigen Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Prostate Specific Antigen Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Prostate Specific Antigen Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Prostate Specific Antigen Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Prostate Specific Antigen Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Prostate Specific Antigen Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Prostate Specific Antigen Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Prostate Specific Antigen Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Prostate Specific Antigen Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Prostate Specific Antigen Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Prostate Specific Antigen Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Prostate Specific Antigen Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Prostate Specific Antigen Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Prostate Specific Antigen market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Prostate Specific Antigen market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Prostate Specific Antigen market is segmented into
    G-115
    INO-5150
    ADXS-PSA
    AEZS-120
    Others

    Segment by Application, the Prostate Specific Antigen market is segmented into
    Prostate Cancer
    Metastatic Hormone Refractory Prostate Cancer
    Others

    Regional and Country-level Analysis
    The Prostate Specific Antigen market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Prostate Specific Antigen market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Prostate Specific Antigen Market Share Analysis
    Prostate Specific Antigen market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Prostate Specific Antigen business, the date to enter into the Prostate Specific Antigen market, Prostate Specific Antigen product introduction, recent developments, etc.

    The major vendors covered:
    Advaxis, Inc.
    Aeterna Zentaris Inc.
    Bavarian Nordic A/S
    Curevac AG
    GenSpera, Inc.
    Inovio Pharmaceuticals, Inc.
    OncBioMune Pharmaceuticals Inc.
    ...

    Buy now